Review
Copyright ©The Author(s) 2023.
World J Orthop. May 18, 2023; 14(5): 275-293
Published online May 18, 2023. doi: 10.5312/wjo.v14.i5.275
Table 2 The first-line anti-tubercular medications' dose, pharmacological activities, and side effects[85]
Anti-tuberculosis drugs
Dose (mg/kg)
Pharmacological activities
Side effects
Isoniazid5-Inhibits the enoyl-ACP reductase InhA of the fatty acid synthase type II (FASII) pathway-Peripheral neuropathy, lethargy, hepatitis, insanity, convulsions, and a lupus-like condition
Rifampicin10-Inhibits messenger RNA elongation by binding to the β-subunit of the RNA polymerase-Hemolytic anemia, gastrointestinal distress, purpura, and orange-red urine stains
Ethambutol15-Inhibits enzyme arabinosyltransferases, glycerol metabolism, and RNA synthesis-Abdominal discomfort, eosinophilia, peripheral neuritis, myocarditis, and hypersensitivity
Pyrazinamide25-Disrupts membrane energetics and inhibits membrane transport function-Hepatotoxicity, pruritis, hyperuricemic arthralgia, and exanthema
Streptomycin15-Binds to the small 16S rRNA of the 30S ribosomal subunit irreversibly, interfering with the binding of formyl-methionyl-tRNA to the 30S subunit-Ototoxicity, rashes, fever, nephrotoxicity, eosinophilia, and vestibulotoxicity